Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Summary of reported mortality from literature

From: Mortality and Clostridium difficile infection: a review

Author

Study type

Country

30-day mortality

Mortality at endpoint (other)

Participants

Arvand, Hauri, Zaiss, Witte & Bettge-Weller (2009)

Prospective multicentre

Germany

25%

-

41

Bhangu, Bhangu, Nightingale & Michael (2010)

Cohort

UK

38%

-

158

Bishara, Peled, Pitlik & Samra (2008)

Case control

Israel

15% case

-

Total 217

   

11.5% control (NS)

 

52 cases

Cadena et al. (2010)

Cohort

US

16%

29% at 90 days

129

Chung et al. (2010)

Cohort

Taiwan

23.3%

37.2% IHM

86

Cloud, Noddin, Pressman, Hu & Kelly (2009)

Cohort

US

-

12.1% IHM

272

Dubberke et al. (2008)

Case control

US

-

38% cases at 180 days

Cohort = 18,050 390 cases

    

12% non-cases at 180 days

 

Fenner et al. (2008)

Cohort

Switzerland

9%

-

78 cases

Gasperino et al. (2010)

Cohort

US

16% cases, 5% controls

20% cases IHM (cases)

216,108 cases

    

8% IHM (controls)

 

Gravel et al. (2009)

Prospective multicentre

Canada

16.3%

-

1430

   

5.7% attributable

  

Gulihar, Nixon, Jenkins & Taylor (2009)

Cohort

UK

19% (cases)

67% cases at 180 days

170 cases

   

9% match cohort

29% matched cohort at 180 days

3,247 matches

Karas, Enoch & Aliyu (2010)

Review

UK

Not applicable

Not applicable

Not applicable

Kenneally et al. (2007)

Cohort

US

36.7%

-

278

   

6.1% attributable

  

Labbe et al. (2008)

Cohort

Canada

23.9%

-

230

Loo et al. (2005)

Prospective multicentre

Canada

24.8%

-

1703

   

6.9% attributable

  

Lyytikainen et al. (2009)

Cohort

Finland

-

14% at 30 days post-discharge

8 093

Marra, Edmond, Wenzel & Bearman (2007)

Cohort

US

 

17.2% at 14 days

58

    

27.6% IHM

 

McGowan et al. (2011)

Cohort

UK

35.5%

13.4% at 7 days

2,571

    

20% at 14 days

 
    

58.7% at 1 year

 

Musher et al. (2005)

Prospective observational

US

-

27% at 90 days

207

Pant et al. (2010)

Cohort

US

13.6%

-

184

Shears, Prtak & Duckworth (2010)

Cohort

UK

24.7%

30.0% at 90 days

227

Sundram et al. (2009)

Case control

UK

14.4% at 28 days (extrapolated)

11% at 3 days (027)

97 cases

    

3% at 3 days (106)

97 controls

Wilson et al. (2010)

Cohort

UK

35.9%

-

128

Zilberberg, Shorr, Micek, Doherty & Kollef (2009)

Cohort. Secondary analysis of Kenneally et al. (2007)

US

26.9% <65 years

-

278

   

45.2% >65

  
  1. Note. IHM = in-hospital mortality.